| Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia A Ehninger, M Kramer, C Röllig, C Thiede, M Bornhäuser, M Von Bonin, ... Blood cancer journal 4 (6), e218-e218, 2014 | 335 | 2014 |
| Chimeric antigen receptor-engineered T cells for immunotherapy of cancer M Cartellieri, M Bachmann, A Feldmann, C Bippes, S Stamova, R Wehner, ... BioMed Research International 2010, 2010 | 272 | 2010 |
| Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts M Cartellieri, A Feldmann, S Koristka, C Arndt, S Loff, A Ehninger, ... Blood cancer journal 6 (8), e458-e458, 2016 | 233 | 2016 |
| Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells A Feldmann, C Arndt, K Töpfer, S Stamova, F Krone, M Cartellieri, ... The Journal of Immunology 189 (6), 3249-3259, 2012 | 116 | 2012 |
| Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR” A Feldmann, C Arndt, R Bergmann, S Loff, M Cartellieri, D Bachmann, ... Oncotarget 8 (19), 31368, 2017 | 111 | 2017 |
| A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform S Albert, C Arndt, A Feldmann, R Bergmann, D Bachmann, S Koristka, ... Oncoimmunology 6 (4), e1287246, 2017 | 99 | 2017 |
| Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system C Arndt, A Feldmann, M Von Bonin, M Cartellieri, EM Ewen, S Koristka, ... Leukemia 28 (1), 59-69, 2014 | 88 | 2014 |
| A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells M Cartellieri, S Koristka, C Arndt, A Feldmann, S Stamova, M von Bonin, ... PLoS One 9 (4), e93745, 2014 | 82 | 2014 |
| Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells C Arndt, M Von Bonin, M Cartellieri, A Feldmann, S Koristka, I Michalk, ... Leukemia 27 (4), 964-967, 2013 | 82 | 2013 |
| “UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells N Mitwasi, A Feldmann, C Arndt, S Koristka, N Berndt, J Jureczek, ... Scientific reports 10 (1), 2141, 2020 | 76 | 2020 |
| Rapidly switchable universal CAR-T cells for treatment of CD123-positive leukemia S Loff, J Dietrich, JE Meyer, J Riewaldt, J Spehr, M von Bonin, C Gründer, ... Molecular Therapy-Oncolytics 17, 408-420, 2020 | 75 | 2020 |
| Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology S Koristka, A Kegler, R Bergmann, C Arndt, A Feldmann, S Albert, ... Journal of Autoimmunity 90, 116-131, 2018 | 69 | 2018 |
| Retargeting of human regulatory T cells by single-chain bispecific antibodies S Koristka, M Cartellieri, A Theil, A Feldmann, C Arndt, S Stamova, ... The Journal of Immunology 188 (3), 1551-1558, 2012 | 67 | 2012 |
| Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats A Feldmann, S Stamova, CC Bippes, H Bartsch, R Wehner, M Schmitz, ... The Prostate 71 (9), 998-1011, 2011 | 67 | 2011 |
| From mono-to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo S Albert, C Arndt, S Koristka, N Berndt, R Bergmann, A Feldmann, ... Oncotarget 9 (39), 25597, 2018 | 65 | 2018 |
| Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B S Koristka, M Cartellieri, C Arndt, CC Bippes, A Feldmann, I Michalk, ... Journal of autoimmunity 42, 105-116, 2013 | 65 | 2013 |
| Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy R Aliperta, PB Welzel, R Bergmann, U Freudenberg, N Berndt, ... Scientific reports 7 (1), 42855, 2017 | 58 | 2017 |
| Adaptor car platforms—Next generation of T cell-based cancer immunotherapy C Arndt, F Fasslrinner, LR Loureiro, S Koristka, A Feldmann, M Bachmann Cancers 12 (5), 1302, 2020 | 50 | 2020 |
| Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells LR Loureiro, A Feldmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Blood cancer journal 8 (9), 81, 2018 | 46 | 2018 |
| Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Oncoimmunology 9 (1), 1785608, 2020 | 45 | 2020 |
